Pioneering India's first cell and gene therapy
Vision
To be a Leader in Cell & Gene Therapy for Patients’ Long-Term Cure through Translational Research in India & beyond
Values
Our spectrum of expertise facilitates a minimalistic approach in developing cell and gene therapy in a pursuit to reach the unreachable
A ccessible and affordable to all
Our clinical collaboration and one-of-a-kind CAR design platform enable us to develop novel, robust, and smarter immune cells
C utting-edge research
We have developed a full-stack company with domain-specific knowledge and state-of-the-art facilities for commercialisation
T ransforming ideas to reality
Director
Parker Institute of Cancer Immunotherapy, University of Pennsylvania, USA
Dr. Carl June, MD
-
Pioneer of world's 1st CAR-T cell therapy
Scientific Advisory Board
Dr. Nirali Shah, MD
Dr. Sattva Neelapu, MD
-
Pioneer in Clinical Studies of CAR-T Cell Therapy
Head of the Hematologic Malignancies Section of the Pediatric Oncology Branch at National Cancer Institute (NCI), NIH, USA.
-
Expert in cancer immunotherapy, including CAR-T Cell therapy for pediatric leukemia.
Business Advisory Board
Dr. Satyanarayana Chava
Founder & CEO, Laurus Labs
Dr. Ravindranath Kancherla
Chairman & MD, Global Hospitals
Innovation Partners
Bench to bedside translation – best in class partners
-
Top rank engineering institute in India
​
-
Institute of Eminence status from Government of India
​
-
R&D Partner for technology development
-
India's largest cancer care center
-
Leader in basic, translational and clinical cancer research
-
Partner for clinical trial and subsequent clinical studies